Skip to main content
. 2017 Dec 5;8(70):115018–115027. doi: 10.18632/oncotarget.22983

Figure 3. Receiver operating characteristic curves for predicting SF3B1 mutation.

Figure 3

Shown are curves in all breast cancer patients (A), in luminal B breast cancer patients (B), and in progesterone receptor (PR)-negative breast cancer patients (C) according to age at diagnosis and estrogen receptor (ER) status.